Cardiovascular Disease Doctors in Yakima, WA Accepting Medicare

11 Cardiovascular Disease doctors found. Showing 1 - 11

Dr. Robert A Ortiz, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1006 S 64th Ave Ste 110, Yakima, WA 98908 Phone: 509-902-3625    Fax: 509-676-3415

Dr. Oscar V. Bailon, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7303 Heathers Way, Yakima, WA 98903 Phone: 201-595-9551

Dao Gia Pham, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 406 S 30th Ave Ste 101, Yakima, WA 98902 Phone: 509-248-7715    Fax: 509-248-2890

Dr. David W Krueger, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1006 S 64th Ave Ste 110, Yakima, WA 98908 Phone: 509-902-3625    Fax: 509-676-3415

Dr. Lucas Fayez Bazi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 406 S 30th Ave Ste 101, Yakima, WA 98902 Phone: 509-248-7715

Dr. Richard K Spiegel, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 406 S 30th Ave, Suite 201, Yakima, WA 98902 Phone: 509-248-7715    Fax: 509-248-2890

Dr. Anatole S Kim, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 611 N 39th Ave, Yakima, WA 98902 Phone: 509-249-1288    Fax: 509-249-1288

Dr. Kevin P Foley, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 406 S 30th Ave, Suite 201, Yakima, WA 98902 Phone: 509-248-7715    Fax: 509-248-2890

Dr. Richard D Twiss, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 406 S 30th Ave, Suite 201, Yakima, WA 98902 Phone: 509-248-7715    Fax: 509-248-2890

Dr. Duane A Monick, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 406 S 30th Ave, Suite 201, Yakima, WA 98902 Phone: 509-248-7715    Fax: 509-248-2890

Dr. Roger E Vielbig, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 406 S 30th Ave, Suite 101, Yakima, WA 98902 Phone: 509-248-7715    Fax: 509-248-2890

News Archive

Psychological scientist examines concept of identity fusion

People who are "fused" with a group-a bond even stronger than group identification-will take extreme actions to protect other group members, but not outsiders, conclude researchers in a new study published in Psychological Science, a journal of the Association for Psychological Science. This intense bond to a group may help explain the actions of suicide bombers.

Commercial non-invasive brain stimulation device impairs cognitive performance

People show impaired memory after receiving low intensity electrical stimulation administered to the frontal part of the brain by a commercial, freely available, device. Psychologists Laura Steenbergen and Lorenza Colzato, with their colleagues at the Leiden Institute of Brain and Cognition and fellow researchers from the Max Planck Institute on Human Development, published their findings in Experimental Brain Research.

New study highlights role played by demographics in the spread of measles

Even if measles infection incidence has decreased by at least 90% all over the world since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases.

Vince and Associates Clinical Research receives 2010 NOVA award

Vince and Associates Clinical Research, a dedicated research facility that conducts clinical trials, recently received the 2010 NOVA award. The Overland Park Chamber of Commerce Economic Development Council developed the award to recognize companies that lead economic growth in the region.

FDA approves Genentech's Erivedge for treatment of BCC

Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

Read more Medical News

› Verified 4 days ago